Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
il y a 940
Canadian Dollar Falls Against Most Majors
The Canadian dollar dropped against its most major counterparts in the New York session on Friday.
RTTNews
|
il y a 7h 59min
Canadian Market Modestly Higher; Technology Stocks Among Notable Gainers
The Canadian market is up in positive territory Friday afternoon with investors largely reacting to quarterly earnings announcements, and the nation's jobs data, in addition to weighing the impact of tariffs on global economic growth.
RTTNews
|
il y a 10h 21min
Swiss Market Ends Marginally Up
The Switzerland market ended marginally up on Friday despite exhibiting weakness for much of the time past noon. Investors continued to react to earnings and assess the economic impact of reciprocal tariffs, and stayed largely cautious with their moves.
A report showing a drop in Swiss consumer confidence in the month of July hurt sentiment.
RTTNews
|
il y a 10h 56min
Major European Markets Close On Mixed Note
Major European markets turned in a mixed performance on Friday with investors largely staying cautious, assessing the impact of tariffs on global economic growth, and continuing to digest corporate earnings announcements and other data.
RTTNews
|
il y a 11h 20min
Positive Start Seen For Canadian Stocks
Canadian stocks may edge up a bit in early trades Friday morning with some encouraging earnings announcements and firm commodity prices aiding sentiment.
Investors will also be reacting to the data showing a 41,000 jobs drop in Canadian employment in the month of July. Data from Statistics Canada also showed that the unemployment rate in Canada came in unchanged at 6.9%.
RTTNews
|
il y a 15h 52min
UK Market Roughly Flat; Mining Stocks Move Higher
Amid a lack of economic and earnings data, U.K. stocks are moving in a tight range in somewhat lackluster trade on Friday. Investors are assessing the potential impact of the Trump administration's reciprocal tariffs on global economic growth. Optimism about a rate cut by the Fed next month is aiding sentiment a bit.
RTTNews
|
il y a 17h 46min
CAC 40 Climbs Higher For 3rd Straight Day
French stocks are modestly higher on Friday, extending gains to a third straight session, with mostly encouraging corporate earnings announcements aiding sentiment.
Concerns about the potential impact of Trump's reciprocal tariffs limit market's upside a bit.
RTTNews
|
il y a 18h 5min
